Page last updated: 2024-08-23

paroxetine and Acute Disease

paroxetine has been researched along with Acute Disease in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (17.86)18.2507
2000's21 (75.00)29.6817
2010's1 (3.57)24.3611
2020's1 (3.57)2.80

Authors

AuthorsStudies
Cornelius, SL; Gui, J; Hoyt, JE; Leonard, CE; Schnurr, PP; Shiner, B; Watts, BV; Young-Xu, Y1
Berk, M; Dodd, S; Kelin, K; Mancini, M; Schacht, A1
Chilton, AP; Elias, E; Hubscher, SG; Milkiewicz, P1
Christensen, J; Clemmensen, PM; Dalsgaard, NJ; Dam, H; Hindberg, I; Lunde, M; Mellerup, E; Plenge, P; Rasmussen, A1
Akiyoshi, J; Fujiki, M; Horinouchi, Y; Isogawa, K; Kodama, K; Nagayama, H; Tsutsumi, T1
Keller, MB1
Allen, A; Burnham, DB; Hollander, E; Oakes, R; Steiner, M; Wheadon, DE1
Duman, EN; Erciyes, N; Kadioglu, M; Kalyoncu, NI; Kesim, M; Yaris, E1
Alkin, T; Bandelow, B; Behnke, K; Clary, CM; Goebel, C; Hendriks, GJ; Lenoir, S1
Hemrick-Luecke, SK; Iyengar, S; Simmons, RM; Webster, AA; Xu, JY1
Casciano, R; Chen, J; Geissler, EC; Mallick, R; Panish, JM; Trivedi, MH; Wan, GJ1
Berger, M; Fiebich, BL; Grunze, H; Lieb, K; Normann, C; Walden, J1
Klemperer, I; Levy, J; Lifshitz, T; Shneck, M; Tessler, Z1
Chen, YC; Lu, RB; Wu, YS1
Kang, EH; Kim, KJ; Lee, IS; Yu, BH1
Barbui, C; Cipriani, A; Furukawa, TA1
Gasbarrini, G; Mascianà, R; Pompili, M; Rapaccini, GL; Tittoto, P1
Lundberg, GD1
Brown, TM; Finkelstein, JA; Magoon, MR; Mareth, TR; Skop, BP1
DeQuardo, JR; DuBose, C; Lewis, CF; Tandon, R1
Baumann, P; Bryois, C; Rubin, C; Zbinden, JD1
Barbone, C; Barsotti, A; Di Girolamo, E; Di Iorio, C; Leonzio, L; Sabatini, P1
Bennett, HG; Wyllie, AM1
Boffa, E; Lofchy, J1
Browning, AC; Chisholm, IH; Nischal, KK; Reck, AC1
Diehn, F; Tefferi, A1
Fava, M; Gonzales, JS; Hoog, SL; Judge, RA; Kopp, JB; Nilsson, ME1
Grunze, H; Hörn, M; Hummel, B; Normann, C; Schärer, LO; Walden, J1

Reviews

5 review(s) available for paroxetine and Acute Disease

ArticleYear
Treatment response for acute depression is not associated with number of previous episodes: lack of evidence for a clinical staging model for major depressive disorder.
    Journal of affective disorders, 2013, Sep-05, Volume: 150, Issue:2

    Topics: Acute Disease; Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Paroxetine; Recurrence; Thiophenes; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride

2013
Paroxetine treatment of major depressive disorder.
    Psychopharmacology bulletin, 2003,Spring, Volume: 37 Suppl 1

    Topics: Acute Disease; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder, Major; Humans; Long-Term Care; Paroxetine; Treatment Outcome

2003
Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2008, Jan-29, Volume: 178, Issue:3

    Topics: Acute Disease; Depression; Humans; Paroxetine; Patient Compliance; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors

2008
[Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case].
    Praxis, 1998, Mar-04, Volume: 87, Issue:10

    Topics: Acute Disease; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Neurologic Examination; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome

1998
Pruritus in polycythaemia vera: prevalence, laboratory correlates and management.
    British journal of haematology, 2001, Volume: 115, Issue:3

    Topics: Acute Disease; Erythrocyte Volume; Female; Humans; Leukocyte Count; Male; Middle Aged; Paroxetine; Patient Satisfaction; Polycythemia Vera; Prevalence; Pruritus; Retrospective Studies; Selective Serotonin Reuptake Inhibitors

2001

Trials

8 trial(s) available for paroxetine and Acute Disease

ArticleYear
Platelet serotonin transporter in stroke patients.
    Acta neurologica Scandinavica, 2003, Volume: 107, Issue:2

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspirin; Binding, Competitive; Biomarkers; Blood Platelets; Carrier Proteins; Chronic Disease; Depression; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Reference Values; Serotonin Plasma Membrane Transport Proteins; Stroke; Time Factors

2003
Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine.
    The Journal of clinical psychiatry, 2003, Volume: 64, Issue:9

    Topics: Acute Disease; Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Humans; Long-Term Care; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Prospective Studies; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2003
Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:3

    Topics: Acute Disease; Adult; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

2004
Serum levels of substance P and response to antidepressant pharmacotherapy.
    Pharmacopsychiatry, 2004, Volume: 37, Issue:5

    Topics: Acute Disease; Adult; Antidepressive Agents; Depressive Disorder, Major; Humans; Lamotrigine; Paroxetine; Severity of Illness Index; Substance P; Surveys and Questionnaires; Triazines

2004
Venlafaxine vs. paroxetine in the acute phase of treatment for major depressive disorder among Han Chinese population in Taiwan.
    Journal of clinical pharmacy and therapeutics, 2007, Volume: 32, Issue:4

    Topics: Acute Disease; Adult; Asian People; China; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Paroxetine; Pharmacogenetics; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2007
Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.
    Journal of the American College of Cardiology, 1999, Volume: 33, Issue:5

    Topics: Acute Disease; Adult; Double-Blind Method; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Refractory Period, Electrophysiological; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Syncope, Vasovagal; Tilt-Table Test; Treatment Outcome

1999
Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.
    Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:2

    Topics: Acute Disease; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Fluoxetine; Humans; Paroxetine; Personality Inventory; Sertraline; Sleep Initiation and Maintenance Disorders; Treatment Outcome

2002
Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Aged; Anticonvulsants; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lamotrigine; Male; Middle Aged; Paroxetine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Triazines

2002

Other Studies

15 other study(ies) available for paroxetine and Acute Disease

ArticleYear
Comparing Medications for DSM-5 PTSD in Routine VA Practice.
    The Journal of clinical psychiatry, 2020, 10-13, Volume: 81, Issue:6

    Topics: Acute Disease; Adult; Carbonic Anhydrase Inhibitors; Female; Fluoxetine; Humans; Male; Medication Adherence; Outcome Assessment, Health Care; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Topiramate; United States; United States Department of Veterans Affairs; Venlafaxine Hydrochloride

2020
Antidepressant induced cholestasis: hepatocellular redistribution of multidrug resistant protein (MRP2).
    Gut, 2003, Volume: 52, Issue:2

    Topics: Acute Disease; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biopsy; Cholestasis; Citalopram; Dothiepin; Female; Humans; Immunohistochemistry; Liver; Male; Middle Aged; Mitochondrial Proteins; Paroxetine; Pregnancy; Pregnancy Complications; Ribosomal Proteins; Saccharomyces cerevisiae Proteins

2003
Anxiety induced by repetitive transcranial magnetic stimulation is suppressed by chronic treatment of paroxetine in rats.
    Pharmacopsychiatry, 2003, Volume: 36, Issue:1

    Topics: Acute Disease; Animals; Anxiety; Chronic Disease; Electric Stimulation; Fear; Male; Maze Learning; Motor Activity; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Transcranial Magnetic Stimulation

2003
Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain.
    Journal of pharmacological sciences, 2004, Volume: 94, Issue:2

    Topics: Acute Disease; Analgesics; Animals; Female; Male; Mice; Narcotic Antagonists; Pain; Paroxetine; Receptors, Opioid; Receptors, Serotonin

2004
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 311, Issue:2

    Topics: Acute Disease; Amines; Amitriptyline; Animals; Conscious Sedation; Cyclohexanecarboxylic Acids; Cyclohexanols; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Methyltyrosines; Milnacipran; Neuromuscular Junction; Norepinephrine; p-Chloroamphetamine; Pain; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Thiophenes; Venlafaxine Hydrochloride

2004
Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.
    Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:5

    Topics: Activities of Daily Living; Acute Disease; Ambulatory Care; Cost-Benefit Analysis; Cyclohexanols; Decision Support Techniques; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Costs; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride

2004
Late bilateral acute angle-closure glaucoma after administration of paroxetine in a patient with plateau iris configuration.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2004, Volume: 39, Issue:7

    Topics: Acute Disease; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Iris; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Ultrasonography

2004
beta-adrenoceptor affinity as a biological predictor of treatment response to paroxetine in patients with acute panic disorder.
    Journal of affective disorders, 2008, Volume: 110, Issue:1-2

    Topics: Acute Disease; Adult; Ambulatory Care; Biomarkers; Control Groups; Cyclic AMP; Female; Humans; Isoproterenol; Lymphocytes; Male; Panic Disorder; Paroxetine; Personality Inventory; Probability; Receptors, Adrenergic, beta; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2008
Acute hepatitis associated with use of paroxetine.
    Internal and emergency medicine, 2008, Volume: 3, Issue:3

    Topics: Acute Disease; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Female; Humans; Liver Function Tests; Paroxetine; Selective Serotonin Reuptake Inhibitors

2008
Placebo as good as paroxetine for treating acute moderate-to-severe major depression.
    Medscape journal of medicine, 2008, Apr-03, Volume: 10, Issue:4

    Topics: Acute Disease; Clinical Trials as Topic; Depressive Disorder, Major; Humans; Paroxetine; Placebo Effect; Treatment Outcome

2008
The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease.
    The American journal of emergency medicine, 1994, Volume: 12, Issue:6

    Topics: Acetaminophen; Acute Disease; Akathisia, Drug-Induced; Blood Platelets; Dextromethorphan; Diagnosis, Differential; Doxylamine; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Endothelium, Vascular; Ephedrine; Humans; Hypertension; Male; Middle Aged; Myoclonus; Nonprescription Drugs; Paroxetine; Peripheral Vascular Diseases; Promethazine; Pseudoephedrine; Sweating; Syndrome

1994
Acute angle-closure glaucoma and paroxetine.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:3

    Topics: Acute Disease; Aged; Depressive Disorder; Female; Glaucoma, Angle-Closure; Humans; Paroxetine

1997
Paroxetine and acute angle-closure glaucoma.
    Eye (London, England), 1999, Volume: 13 ( Pt 5)

    Topics: Acute Disease; Antidepressive Agents, Second-Generation; Female; Glaucoma, Angle-Closure; Humans; Middle Aged; Paroxetine

1999
Paroxetine and tardive akathisia.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2000, Volume: 45, Issue:4

    Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors

2000
Acute angle closure glaucoma presenting in a young patient after administration of paroxetine.
    Eye (London, England), 2000, Volume: 14 ( Pt 3A)

    Topics: Acute Disease; Adult; Antidepressive Agents, Second-Generation; Glaucoma, Angle-Closure; Humans; Male; Paroxetine

2000